In vitro adsorption study of fluoxetine onto activated charcoal at gastric and intestinal pH using high performance liquid chromatography with fluorescence detector

Journal of Toxicology - Clinical Toxicology

Volumn 35, Issue 3, 1997, Pages 269-276

  Tsitoura, Argero ^a   Atta Politou, Julia ^a   Koupparis, Michael A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; CHARCOAL; FLUOXETINE;

ARTICLE; DRUG ADSORPTION; DRUG BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; STOMACH PH;

EID: 0030959655     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659709001211     Document Type: Article

References (47)

1. Flomenbaum NE, Goldfrank LR, Weisman RS, Howland MA, Lewin NA, Kulberg AG. General management of the poisoned or overdosed patient. In: Goldfrank's Toxicologic Emergencies, 4th ed. Goldfrank LR, Flomenbaum NE, Lewin NA, et al., eds., Norfolk, CT: Appleton & Lange, 1990:5-20.
2. Ellenhorn MJ, Barceloux DJ. Gut decontamination. In: Medical Toxicology: Diagnosis and Treatment of Human Poisoning. Ellenhorn MJ, Barceloux DJ, eds., New York: Elsevier, 1988: 54-63.
3. Neuvonen PJ, Olkkola KT. Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses. Med Toxicol Adverse Drug Exp 1988;3:33-58.
4. Cooney DO. Effects of activated charcoal on various types of drugs and poisons. In: Activated Charcoal - Antidotal and Other Medical Uses. Cooney DO, ed., New York:Marcel Dekker Inc., 1980:84-120.
5. Pond SM. Role of repeated oral doses of activated charcoal in clinical toxicology. Med Toxicol 1986;1:3-11.
6. Klaasen CD. Principles of toxicology and treatment of poisoning. In: Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 9th ed. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, eds., New York: McGraw-Hill, 1996:63-75.
7. Benfield P, Heel RC, Lewis SP. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1986;32:481-508.
8. Harris MG, Benfield P. Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in older patients with depressive illness. Drugs Aging 1995;6:64-84.
9. Sommi RW, Crismon LM, Bowden CL. Fluoxetine: a serotonin-specific, second-generation antidepressant. Pharmacotherapy 1987;7:1-15.
10. Masand P, Gupta S, Dewan M. Suicidal ideation related to fluoxetine treatment. N Engl J Med 1991;324:420.
11. Papp LA, Gorman JM. Suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990;147:1380-1381.
12. Miller RA. Discussion of fluoxetine and suicidal tendencies. Am J Psychiatry 1990;147:1571-1572.
13. Tollefson GD. Fluoxetine and suicidal ideation. Am J Psychiatry 1990;147:1691-1693.
14. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 1995;310:215-218.
15. Gessner PK, Hasan MM. Freundlich and Langmuir isotherms as models for the adsorption of toxicants on activated charcoal. J Pharm Sci 1987;76:319-327.
16. Tsuchiya T, Levy G. Relationship between effect of activated charcoal on drug adsorption in man and its drug adsorption characteristics in vitro. J Pharm Sci 1972;61:586-589.
17. Sorby DL. Effect of adsorbents on drug absorption. I. Modification of promazine absorption by activated attapulgite and activated charcoal. J Pharm Sci 1965;54:677-683.
18. Suckow RF, Zhang MF, Cooper TB. Sensitive and selective liquid-chromatographic assay of fluoxetine and norfluoxetine in plasma with fluorescence detection after precolumn derivatization. Clin Chem 1992;38:1756-1761.
19. Gupta RN, Steiner M. Determination of fluoxetine and norfluoxetine in serum by liquid chromatography with fluorescence detection. J Liq Chromatogr 1990;13:3785-3797.
20. Thomare P, Wang K, Van der Meersch-Mougeot V, Diquet B. Sensitive micromethod for column liquid chromatographic determination of fluoxetine and norfluoxetine in human plasma. J Chromatogr 1992;583:217-221.
21. Wong SH, Dellafera SS, Fernandes R, Kranzler H. Determination of fluoxetine and norfluoxetine by high-performance liquid chromatography. J Chromatogr 1990;499:601-608.
22. Nichols JH, Charlson JR, Lawson GM. Automated HPLC assay of fluoxetine and norfluoxetine in serum. Clin Chem 1994;40:1312-1316.
23. Orsulak PJ, Kenney JT, Debus JR, Crowley G, Wittman PD. Determination of the antidepressant fluoxetine and its metabolite norfluoxetine in serum by reversed-phase HPLC with ultraviolet detection. Clin Chem 1988;34:1875-1878.
24. Atta-Politou J, Macheras PE, Koupparis MA. The effect of polyethylene glycol on the charcoal adsorption of chlorpromazine studied by ion selective electrode potentiometry. J Toxicol Clin Toxicol 1996;34:307-316.
25. Makosiej FJ, Hoffman RS, Howland MA, Goldfrank LR. An in vitro evaluation of cocaine hydrochloride adsorption by activated charcoal and desorption upon addition of polyethylene glycol electrolyte lavage solution. J Toxicol Clin Toxicol 1993;31:381-395.
26. Tomaszewski C, Voorhees S, Wathen J, Brent J, Kulig K. Cocaine adsorption to activated charcoal in vitro. J Emerg Med 1992;10:59-62.
27. Andersen AH. Experimental studies on the pharmacology of activated charcoal. II. The effect of pH on the adsorption by charcoal from aqueous solutions. Acta Pharmacol 1947;3:199-218.
28. Wernicke JF. The side effect profile and safety of fluoxetine. J Clin Psychiatry 1985;46:59-67.
29. Moore JL, Rodriguez R. Toxicity of fluoxetine overdose. Am J Psychiatry 1990;147:1089.
30. Finnegan KT, Gabiola JM. Fluoxetine overdose. Am J Psychiatry 1988;145:1604.
31. Riddle MA, Brown N, Dzubinski D, Jetmalani AN, Law Y, Woolston JL. Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry 1989;28:587-588.
32. Kim SW, Pentel PR. Flu-like symptoms associated with fluoxetine overdose: a case report. J Toxicol Clin Toxicol 1989;27:389-393.
33. Spiller HA, Morse S, Muir C. Fluoxetine ingestion: a one year retrospective study. Vet Hum Toxicol 1990;32:153-155.
34. Borys DJ, Setzer SC, Ling LJ, Reisdorf JJ, Day LC, Krenzelok EP. The effects of fluoxetine in the overdose patient. J Toxicol Clin Toxicol 1990;28:331-340.
35. Bost RO, Kemp PM. A possible association between fluoxetine use and suicide. J Anal Toxicol 1992;16: 142-145.
36. Prozac®-Dista, Product Information, Physician's Desk Reference (PDR) 50th ed, Medical Economics, 1990:919-923.
37. Kincaid RL, McMullin MM, Crookham SB, Rieders F. Report of a fluoxetine fatality. J Anal Toxicol 1990;14:327-329.
38. Rohrig TP, Prouty RW. Fluoxetine overdose: a case report. J Anal Toxicol 1989;13:305-307.
39. Downs JC, Conradi SE, Nichols CA. Suicide by environmental hypoxia (forced depletion of oxygen). Am J Forensic Med Pathol 1994;15:216-223.
40. Power BM, Pinder M, Hackett LP, Ilett KF. Fatal serotonin syndrome following a combined overdose of moclobemide, clomipramine and fluoxetine. Anaesth Intensive Care 1995;23:499-502.
41. Hoffman RS, Chiang WK, Howland MA, Weisman RS, Goldfrank LR. Theophylline desorption from activated charcoal caused by whole bowel irrigation solution. J Toxicol Clin Toxicol 1991;29:191-201.
42. Arimori K, Deshimaru M, Furukawa E, Nakano M. Adsorption of mexiletine onto activated charcoal in macrogol-electrolyte solution. Chem Pharm Bull Tokyo 1993;41:766-768.
43. Kirshenbaum LA, Sitar DS, Tenenbein M. Interaction between whole-bowel irrigation solution and activated charcoal: implications for the treatment of toxic ingestions. Ann Emerg Med 1990;19:1129-1132.
44. Oderda GM, Klein-Scwartz W, Insley BM. In vitro study of boric acid and activated charcoal. J Toxicol Clin Toxicol 1987;25:13-19.
45. Favin FD, Klein-Schwartz W, Oderda GM, Rose SR. In vitro study of lithium carbonate adsorption by activated charcoal. J Toxicol Clin Toxicol 1988;26: 443-450.
46. Akintonwa A, Orisakwe OE. The adsorption of quinine and quinidine to activated charcoal with and without magnesium sulfate. Vet Hum Toxicol 1990;32:567-568.
47. Atta-Politou J, Koupparis M, Macheras P. Development of a potentiometric kinetic method for drug adsorption studies: The chlorpromazine-charcoal model case. Eur J Pharm Sci 1996;4:223-230.